Porvair Sciences

New Module on Agilent Alissa Clinical Informatics Platform

Agilent Technologies Inc.

Impact Support Mats Protect Microplates During Centrifugation

Porvair Sciences

Range of Application Optimized Evaporators

Genevac

sphingotec is Adding an Advanced POC Testing Platform to Portfolio

POC testing of penKid® and bio-ADM® is set to add significant clinical benefit to emergency departments and intensive care units allowing on-site diagnosis, monitoring, and guidance in therapies of sepsis, decongestion in heart failure and acute kidney injury, thereby improving outcomes in acute heart failure, sepsis and other acute settings.

Biotech Support Group LLC Files Patent Application for Stroma Liquid Biopsy™

Methods to monitor and potentially modulate the systemic response to cancer, offer new avenues for early detection, personalized medicine and therapeutic modalities.

Cambridge Research Biochemicals to Support Preclinical Study on Treatment for Vision-Damaging Eye Disease

Under a new contract, Cambridge Research Biochemicals® will support evaluation of a potential new treatment approach for Fuchs Dystrophy, a disease that typically occurs in middle age and may cause a gradual loss of vision.

Bio-Rad Launches a Range of Anti-idiotypic Antibodies Targeting Pembrolizumab and Nivolumab

Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, announced the launch of a range of anti-idiotypic antibodies targeting the immune checkpoint inhibitor drugs.